The unveiling ceremony was held in Tehran on Tuesday in a ceremony participated by AEOI chief Mohammad Eslami.
The unveiled radiopharmaceuticals were three drugs for diagnosing brain tumors including, 64Cu-DOTATATE, 64Cu-PSMA and 177Lu-CXCR4.
Despite the US propaganda against Iran’s nuclear program, Iran has always stressed that the program is purely peaceful with civilian aims, including the production of radiopharmaceuticals.
9341**2050